All Pharma News
Mydecine Receives Two Notice of Allowances from USPTO for MYCO-005 and MYCO-006

Mydecine Receives Two Notice of Allowances from USPTO for MYCO-005 and MYCO-006
GLOBENEWSWIRE
07 Feb 2024
Share Share
Mydecine Announces Update Regarding the Special Access Program

Mydecine Announces Update Regarding the Special Access Program
GLOBENEWSWIRE
28 Nov 2023
Share Share
Mydecine Innovations Announces Closing Under Share Subscription Agreements

Mydecine Innovations Announces Closing Under Share Subscription Agreements
GLOBENEWSWIRE
31 Oct 2023
Share Share
Mydecine Provides Q4 2023 Business Update

Mydecine Provides Q4 2023 Business Update
GLOBENEWSWIRE
26 Oct 2023
Share Share
Mydecine Announces Admission to Trading on the AQSE Growth Market in London, UK

Mydecine Announces Admission to Trading on the AQSE Growth Market in London, UK
GLOBENEWSWIRE
12 Oct 2023
Share Share
Mydecine Innovations Group Announces Admission to Trading on the AQSE

Mydecine Innovations Group Announces Admission to Trading on the AQSE
GLOBENEWSWIRE
10 Oct 2023
Share Share
MydecineAnnounces Listing on the Canadian Securities Exchange

MydecineAnnounces Listing on the Canadian Securities Exchange
GLOBENEWSWIRE
05 Oct 2023
Share Share
Mydecine Innovations Group Announces Expected U.K. Dual Listing Admission Date

Mydecine Innovations Group Announces Expected U.K. Dual Listing Admission Date
GLOBENEWSWIRE
27 Sep 2023
Share Share
Mydecine Innovations Announces Closing of Prospectus Supplement Financing

Mydecine Innovations Announces Closing of Prospectus Supplement Financing
GLOBENEWSWIRE
19 Sep 2023
Share Share
Mydecine Innovations Group Files Prospectus Supplement

Mydecine Innovations Group Files Prospectus Supplement
GLOBENEWSWIRE
15 Sep 2023
Share Share